Astonea Labs IPO

1.46x

subscribed

Astonea Labs IPO

Pharmaceuticals & Drugs
listed
₹1.28LMin. investment
  1. Pre-apply
    23 May
  2. Bid start
    27 May
  3. Bid end
    29 May
  4. Allotment
    30 May
  5. Release of funds
    2 Jun
  6. Demat transfer
    2 Jun
  7. Listing
    3 Jun

Astonea Labs Limited IPO Details

SectorPharmaceuticals & Drugs
Price range₹128 – ₹135
IPO type
SME
Lot size1000 shares
Issue size₹37Cr
Red Herring Prospectus
Read
Market Cap
₹141.9CrLower than sector avg
RevenueApr 2023 - Mar 2024
₹80.19CrLower than sector avg
Growth rate3Y CAGR
63.33%

Checklist

Quality analysis
Revenue growth
Company valuation
Earnings expansion
Risk analysis
Debt to Equity ratio
Promoter holdings
Shares pledged
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Compare

Companies in this sector
Sun Pharmaceutical Industries LtdSun Pharmaceutical Industries Ltd
Divi's Laboratories LtdDivi's Laboratories Ltd
Torrent Pharmaceuticals LtdTorrent Pharmaceuticals Ltd
Revenue
Higher revenue means strong sales and good market demand
This IPO
₹80.19Cr
This sector
₹1,331.47Cr
Compare with companies
PAT
Higher PAT means strong profitability and efficient cost management
This IPO
₹3.81Cr
This sector
₹193.4Cr
Compare with companies
Market cap
Higher market cap means strong confidence but may suggest overvaluation
This IPO
₹141.9Cr
This sector
₹10,914.84Cr
Compare with companies
P/E ratio
Lower ratio usually means stock is undervalued
This IPO
26.95
This sector
60.87
Compare with companies
D/E ratio
Lower ratio usually means fewer liabilities
This IPO
1.70
This sector
0.43
Compare with companies

Objectives

Working capital requirements
52.42%
Purchase and installation of plant and machinery
13.80%
Advertising, marketing and brand building
13.14%
Capital expenditure
3.40%
Investment in procuring hardware and software
1.80%

About Astonea Labs Limited

Incorporated in 2017, Astonea Labs is a Haryana-based company engaged in the manufacturing and marketing of pharmaceutical and cosmetic products. Its offerings include a wide range of medicines and personal care items, produced at a 7,500 sq. m. ISO-compliant facility. The company also operates under its own brands, “Glow up” and "Regero," available online, and plans to launch "Avicel." It also undertakes contract manufacturing and exports to markets such as Iraq and Yemen.

Astonea Labs IPO Subscription Status

Date
QIB
NII
Retail
Total
27-May-25
0.0 times (X)
0.1 times (X)
0.33 times (X)
0.13 times (X)
28-May-25
0.11X
0.16X
0.68X
0.32X
29-May-25
0.7X
3.48X
1.67X
1.46X

Frequently asked questions

How to invest in the Astonea Labs IPO ?

Investors can apply for the Astonea Labs IPO through their Demat account via the stock exchange or through their broker.

What is the issue size of Astonea Labs IPO ?

The issue size of the Astonea Labs IPO is 37 Cr.

What is 'pre-apply' for Astonea Labs IPO ?

Pre-applying for an IPO allows you to submit your application before the official subscription period begins.

Which exchanges will Astonea Labs IPO shares list on?

The IPO shares will typically list on major stock exchanges such as the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), as specified in the IPO prospectus.